Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000154565 | SCV000171620 | benign | not specified | 2014-04-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000154565 | SCV000204238 | benign | not specified | 2012-04-04 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Labcorp Genetics |
RCV000232413 | SCV000284648 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000154565 | SCV000338989 | likely benign | not specified | 2016-01-21 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770204 | SCV000901633 | benign | Cardiomyopathy | 2015-09-17 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000154565 | SCV001476085 | benign | not specified | 2020-08-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154565 | SCV001572359 | benign | not specified | 2021-04-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390294 | SCV002701837 | likely benign | Inborn genetic diseases | 2022-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000232413 | SCV003931783 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233108 | SCV003931784 | likely benign | Dilated cardiomyopathy 1L | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003915272 | SCV004729636 | likely benign | SGCD-related disorder | 2020-01-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |